Weight-loss drug may be launched in India next year, says Eli Lilly CEO David Ricks

US drug maker Eli Lilly plans to launch its weight-loss drugs Zepbound and Mounjaro in India next year. The company is considering pricing based on supply and volume expansion. Eli Lilly CEO David Ricks suggests focusing on digital services in the Indian healthcare industry to encourage innovation and improve access to healthcare.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news